Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-25-000046
Filing Date
2025-05-05
Accepted
2025-05-05 16:19:46
Documents
124
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20250331.htm   iXBRL 10-Q 1297325
2 EX-10.22 vandalicenseagreement-re.htm EX-10.22 183234
3 EX-31.1 anab-3312025x10qxexx311.htm EX-31.1 8449
4 EX-31.2 anab-3312025x10qxexx312.htm EX-31.2 8300
5 EX-32.1 anab-3312025x10qxexx321.htm EX-32.1 4970
6 EX-32.2 anab-3312025x10qxexx322.htm EX-32.2 4862
12 anab-20250331_g1.jpg GRAPHIC 78625
13 vandalicenseagreement-re001.jpg GRAPHIC 60962
14 vandalicenseagreement-re002.jpg GRAPHIC 187555
15 vandalicenseagreement-re003.jpg GRAPHIC 192404
16 vandalicenseagreement-re004.jpg GRAPHIC 199277
17 vandalicenseagreement-re005.jpg GRAPHIC 52163
18 vandalicenseagreement-re006.jpg GRAPHIC 244749
19 vandalicenseagreement-re007.jpg GRAPHIC 247833
20 vandalicenseagreement-re008.jpg GRAPHIC 275751
21 vandalicenseagreement-re009.jpg GRAPHIC 282884
22 vandalicenseagreement-re010.jpg GRAPHIC 291246
23 vandalicenseagreement-re011.jpg GRAPHIC 238895
24 vandalicenseagreement-re012.jpg GRAPHIC 225260
25 vandalicenseagreement-re013.jpg GRAPHIC 257272
26 vandalicenseagreement-re014.jpg GRAPHIC 273039
27 vandalicenseagreement-re015.jpg GRAPHIC 219750
28 vandalicenseagreement-re016.jpg GRAPHIC 276639
29 vandalicenseagreement-re017.jpg GRAPHIC 184906
30 vandalicenseagreement-re018.jpg GRAPHIC 250969
31 vandalicenseagreement-re019.jpg GRAPHIC 294709
32 vandalicenseagreement-re020.jpg GRAPHIC 291370
33 vandalicenseagreement-re021.jpg GRAPHIC 293733
34 vandalicenseagreement-re022.jpg GRAPHIC 291471
35 vandalicenseagreement-re023.jpg GRAPHIC 213265
36 vandalicenseagreement-re024.jpg GRAPHIC 271717
37 vandalicenseagreement-re025.jpg GRAPHIC 298433
38 vandalicenseagreement-re026.jpg GRAPHIC 298816
39 vandalicenseagreement-re027.jpg GRAPHIC 227264
40 vandalicenseagreement-re028.jpg GRAPHIC 274505
41 vandalicenseagreement-re029.jpg GRAPHIC 292341
42 vandalicenseagreement-re030.jpg GRAPHIC 306087
43 vandalicenseagreement-re031.jpg GRAPHIC 281958
44 vandalicenseagreement-re032.jpg GRAPHIC 306469
45 vandalicenseagreement-re033.jpg GRAPHIC 299107
46 vandalicenseagreement-re034.jpg GRAPHIC 240362
47 vandalicenseagreement-re035.jpg GRAPHIC 269268
48 vandalicenseagreement-re036.jpg GRAPHIC 273354
49 vandalicenseagreement-re037.jpg GRAPHIC 306961
50 vandalicenseagreement-re038.jpg GRAPHIC 273443
51 vandalicenseagreement-re039.jpg GRAPHIC 300666
52 vandalicenseagreement-re040.jpg GRAPHIC 278611
53 vandalicenseagreement-re041.jpg GRAPHIC 309633
54 vandalicenseagreement-re042.jpg GRAPHIC 305380
55 vandalicenseagreement-re043.jpg GRAPHIC 328281
56 vandalicenseagreement-re044.jpg GRAPHIC 270387
57 vandalicenseagreement-re045.jpg GRAPHIC 267990
58 vandalicenseagreement-re046.jpg GRAPHIC 294388
59 vandalicenseagreement-re047.jpg GRAPHIC 167827
60 vandalicenseagreement-re048.jpg GRAPHIC 293870
61 vandalicenseagreement-re049.jpg GRAPHIC 38155
62 vandalicenseagreement-re050.jpg GRAPHIC 69822
  Complete submission text file 0001370053-25-000046.txt   24983221

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20250331.xsd EX-101.SCH 58732
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20250331_cal.xml EX-101.CAL 55145
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20250331_def.xml EX-101.DEF 237563
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20250331_lab.xml EX-101.LAB 668081
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20250331_pre.xml EX-101.PRE 450404
127 EXTRACTED XBRL INSTANCE DOCUMENT anab-20250331_htm.xml XML 1039524
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 25913269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)